Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease. FOSFASTUR study

MLA

J Emilio, Sanchez-Alvarez, et al. “Efficacy and Safety of Sucroferric Oxyhydroxide in the Treatment of Hyperphosphataemia in Chronic Kidney Disease. FOSFASTUR Study.” Nefrologia, vol. 41, no. 1, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........94b3772d3529afd6effabb2374cc274e&authtype=sso&custid=ns315887.

APA

J Emilio, S.-A., Elena, A. C., Miguel, S. M., Raúl, G. C., Carlos Miguel, H. O., Ana Cristina, A. L., Catalina, U. C., Anna, G. P., & Carmen, R. S. (2020). Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease. FOSFASTUR study. Nefrologia, 41(1).

Chicago

J Emilio, Sanchez-Alvarez, Astudillo Cortes Elena, Seras Mozas Miguel, García Castro Raúl, Hidalgo Ordoñez Carlos Miguel, Andrade López Ana Cristina, Ulloa Clavijo Catalina, Gallardo Pérez Anna, and Rodríguez Suárez Carmen. 2020. “Efficacy and Safety of Sucroferric Oxyhydroxide in the Treatment of Hyperphosphataemia in Chronic Kidney Disease. FOSFASTUR Study.” Nefrologia 41 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........94b3772d3529afd6effabb2374cc274e&authtype=sso&custid=ns315887.